loratadine has been researched along with Drop Attack in 2 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carroll, C | 1 |
Hassanin, A | 1 |
Fukumoto, T | 1 |
Ogura, K | 1 |
Fukunaga, A | 1 |
Nishigori, C | 1 |
2 other studies available for loratadine and Drop Attack
Article | Year |
---|---|
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Atorvastatin; Atrial Fibrillatio | 2017 |
Aquagenic urticaria: Severe extra-cutaneous symptoms following cold water exposure.
Topics: Child; Chronic Inducible Urticaria; Cold Temperature; Dyspnea; Female; Histamine H1 Antagonists, Non | 2018 |